Immunitybio Stock Price on June 4, 2021
| IBRX Stock | USD 4.82 0.67 12.20% |
Below is the normalized historical share price chart for Immunitybio extending back to July 28, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Immunitybio stands at 4.82, as last reported on the 25th of April, with the highest price reaching 5.72 and the lowest price hitting 4.79 during the day.
If you're considering investing in Immunitybio Stock, it is important to understand the factors that can impact its price. Immunitybio appears to be very risky, given 3 months investment horizon. Immunitybio holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12% return per unit of risk over the last 3 months. By evaluating Immunitybio's technical indicators, you can evaluate if the expected return of 0.96% is justified by implied risk. Please utilize Immunitybio's Downside Deviation of 8.07, market risk adjusted performance of 0.1981, and Risk Adjusted Performance of 0.0867 to validate if our risk estimates are consistent with your expectations.
At this time, Immunitybio's Common Stock Total Equity is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 2.5 B in 2024, despite the fact that Total Stockholder Equity is likely to grow to (557.6 M). . Price To Sales Ratio is likely to drop to 3,900 in 2024. Price Earnings Ratio is likely to drop to -4.6 in 2024. Immunitybio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of July 2015 | 200 Day MA 3.4132 | 50 Day MA 5.166 | Beta 0.039 |
Immunitybio |
Sharpe Ratio = 0.1197
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IBRX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.98 actual daily | 70 70% of assets are less volatile |
Expected Return
| 0.96 actual daily | 19 81% of assets have higher returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average Immunitybio is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immunitybio by adding it to a well-diversified portfolio.
Enterprise Value Ebitda (8.99) | Price Sales 5.6 K | Shares Float 145.3 M | Wall Street Target Price 5 | Earnings Share (1.15) |
Immunitybio Valuation on June 4, 2021
It is possible to determine the worth of Immunitybio on a given historical date. On June 4, 2021 Immunitybio was worth 5.06 at the beginning of the trading date compared to the closed value of 4.93. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Immunitybio stock. Still, in general, we apply an absolute valuation method to find Immunitybio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Immunitybio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Immunitybio's related companies.
| Open | High | Low | Close | Volume | |
04/11/2022 | 5.06 | 5.16 | 4.90 | 4.93 | 1,399,200 |
| 5.25 | 5.30 | 4.91 | 5.01 | 1,406,900 |
| Backtest Immunitybio | | | Immunitybio History | | | Immunitybio Valuation | Next |
Immunitybio Trading Date Momentum on June 4, 2021
The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.Immunitybio Fundamentals Correlations and Trends
By evaluating Immunitybio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Immunitybio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Immunitybio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Immunitybio Stock history
Immunitybio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Immunitybio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Immunitybio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Immunitybio stock prices may prove useful in developing a viable investing in Immunitybio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 508.6 M | 399.6 M | |
| Net Loss | -374.9 M | -356.2 M |
Immunitybio Stock Technical Analysis
Immunitybio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Immunitybio Period Price Range
Low | April 11, 2022
| High |
5.06 | 4.93 |
Immunitybio April 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Immunitybio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Immunitybio shares will generate the highest return on investment. By undertsting and applying Immunitybio stock market strength indicators, traders can identify Immunitybio entry and exit signals to maximize returns
Immunitybio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Immunitybio's price direction in advance. Along with the technical and fundamental analysis of Immunitybio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Immunitybio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0867 | |||
| Jensen Alpha | 0.515 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.1063 | |||
| Treynor Ratio | 0.1881 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunitybio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Immunitybio Stock please use our How to Invest in Immunitybio guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Immunitybio Stock analysis
When running Immunitybio's price analysis, check to measure Immunitybio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunitybio is operating at the current time. Most of Immunitybio's value examination focuses on studying past and present price action to predict the probability of Immunitybio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunitybio's price. Additionally, you may evaluate how the addition of Immunitybio to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |
Is Immunitybio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunitybio. If investors know Immunitybio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunitybio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.15) | Revenue Per Share 0.001 | Quarterly Revenue Growth 0.904 | Return On Assets (0.52) |
The market value of Immunitybio is measured differently than its book value, which is the value of Immunitybio that is recorded on the company's balance sheet. Investors also form their own opinion of Immunitybio's value that differs from its market value or its book value, called intrinsic value, which is Immunitybio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunitybio's market value can be influenced by many factors that don't directly affect Immunitybio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunitybio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunitybio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunitybio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.